The Future of Scientific Meetings

FEATUREScientific Meetings © Erik Dreyer/Getty Images Less time, more conferences, and better mobile technology: Meeting planners struggle with the challenges facing the industryBY KEITH O'BRIENIn late 2003, a handful of scientists-turned-conference-planners met at the Yale Club in midtown Manhattan. The big players of scientific conference planning - Gordon Research Conferences, Keystone Symposia, and Cold Spring Harbor Laboratory - were

Written byKeith O' Brien
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Less time, more conferences, and better mobile technology: Meeting planners struggle with the challenges facing the industry

In late 2003, a handful of scientists-turned-conference-planners met at the Yale Club in midtown Manhattan. The big players of scientific conference planning - Gordon Research Conferences, Keystone Symposia, and Cold Spring Harbor Laboratory - were all there. And they were joined by representatives from the Jackson Laboratory in Maine and the American Association for Cancer Research (AACR).

It was a typical working-lunch affair, complete with Power Point presentations, brief talks, and then informal discussion. Nothing very exciting, but the fact that these competitors decided to meet formally for the first time revealed a sign of the times. "We were becoming concerned that the field was getting bloated with meetings," says John Macauley, senior director of courses and conferences for Jackson Lab.

No industry clearinghouse exists that keeps data on the number of meetings ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies